Aspire Biopharma Holdings, Inc. (ASBP)

Aspire Biopharma Holdings Statistics

Total Valuation

ASBP has a market cap or net worth of $19.51 million. The enterprise value is $24.93 million.

Market Cap	19.51M
Enterprise Value	24.93M

Important Dates

The last earnings date was Wednesday, August 13, 2025, after market close.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

ASBP has 48.90 million shares outstanding. The number of shares has increased by 77.18% in one year.

Current Share Class	48.90M
Shares Outstanding	48.90M
Shares Change (YoY)	+77.18%
Shares Change (QoQ)	-91.39%
Owned by Insiders (%)	23.17%
Owned by Institutions (%)	8.62%
Float	34.70M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.22

Current Ratio	0.22
Quick Ratio	0.15
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-6.20

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	34.84%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, ASBP has paid $1,013 in taxes.

Income Tax	1,013
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -96.48% in the last 52 weeks. The beta is 0.80, so ASBP's price volatility has been lower than the market average.

Beta (5Y)	0.80
52-Week Price Change	-96.48%
50-Day Moving Average	0.35
200-Day Moving Average	4.87
Relative Strength Index (RSI)	54.11
Average Volume (20 Days)	872,585

Short Selling Information

The latest short interest is 1.10 million, so 2.24% of the outstanding shares have been sold short.

Short Interest	1.10M
Short Previous Month	2.42M
Short % of Shares Out	2.24%
Short % of Float	3.16%
Short Ratio (days to cover)	0.02

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-2.41M
Pretax Income	n/a
Net Income	-17.02M
EBITDA	n/a
EBIT	-2.41M
Earnings Per Share (EPS)	-$0.35

Balance Sheet

The company has $1.35 million in cash and $6.76 million in debt, giving a net cash position of -$5.42 million or -$0.11 per share.

Cash & Cash Equivalents	1.35M
Total Debt	6.76M
Net Cash	-5.42M
Net Cash Per Share	-$0.11
Equity (Book Value)	-6.95M
Book Value Per Share	-0.14
Working Capital	-6.90M

Cash Flow

Operating Cash Flow	-1.82M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ASBP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-77.18%
Shareholder Yield	-77.18%
Earnings Yield	-87.23%
FCF Yield	n/a

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1